基于Zwitterionic Sulfadiazine的小胞通过克服多个生物障碍,有效地向质母细胞瘤输送药物
Ke Zheng1, Xumei Ouyang2,3, Jing Li3
1School of Materials Science and Engineering, Dongguan University of Technology, 1 University Road, Dongguan, 523808, China.
Journal of the American Chemical Society
|September 6, 2025
概括
一种新型的zwitterionic纳米粒子 (PCL-PSDMA) 能够有效地克服质母细胞瘤治疗的生物障碍. 这种极简的纳米粒子设计在临床前模型中增强了药物输送和抗瘤效果.
科学领域:
- 生物材料科学
- 纳米技术
- 提供药物
背景情况:
- 在体内生物障碍限制了纳米粒子 (NP) 传递到瘤.
- 复杂的NP设计阻碍了临床转化,在有效性和简单性之间产生了困境.
研究的目的:
- 开发一种简单的纳米粒子,具有能够克服多种生物障碍的质母细胞瘤药物输送结构.
主要方法:
- 通过原子转移基聚合 (ATRP) 合成基聚烯酸 (PCL-PSDMA) 微粒.
- 在生理,血脑屏障,瘤细胞外和溶酶体环境中评估PCL-PSDMA菌细胞行为.
- 在质母细胞瘤小鼠模型中评估药物递送效率和抗瘤作用.
主要成果:
- PCL-PSDMA小胞体表现出体状态,确保长时间的血液循环,避免加速的血液清除.
- 微粒通过l型氨基酸载体的介导有效地穿越血脑屏障.
- 在瘤中,Zwitterionic转换为正电荷增强了透和细胞吸收,随后发生了 lysosomal escape.
- 在质母细胞瘤模型中显示出高药物递送效率和显著的抗瘤作用.
结论:
- 最简单的PCL-PSDMA细胞成功地克服了五个连续的生物障碍.
- 这种zwitterionic纳米粒子平台为抗质母细胞瘤药物输送提供了一个有前途的策略,扩大了纳米粒子开发的范围.
更多相关视频
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
2.5K
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.8K
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
